The population of infants at risk for retinopathy of prematurity (ROP) varies by world region;
in countries with well developed neonatal intensive care services, the highest risk infants are …

The light‐sensitive photoreceptors in the retina are extremely metabolically demanding and
have the highest density of mitochondria of any cell in the body. Both physiological and …

OBJECTIVE: Among extremely preterm infants, we evaluated whether bevacizumab therapy
compared with surgery for retinopathy of prematurity (ROP) is associated with adverse …

Objective To systematically review the studies exploring the association between
bevacizumab and neurodevelopmental outcomes. Methods Embase, Medline, CINAHL, and …

Introduction Laser photocoagulation is the current gold standard treatment for proliferative
retinopathy of prematurity (ROP). However, it permanently reduces the visual field and might …

Objective To evaluate safety and efficacy of oral propranolol administration in preterm
newborns affected by an early phase of retinopathy of prematurity (ROP). Study design Fifty …

Retinopathy of prematurity (ROP) is a vasoproliferative disease of developing retinal vessels
that affects premature infants and can lead to severe and irreversible visual loss if left …

Retinopathy of prematurity (ROP), a significant morbidity in prematurely born infants, is the
most common cause of visual impairment and blindness in children and persists till …

The tightly structured neural retina has a unique vascular network comprised of three
interconnected plexuses in the inner retina (and choroid for outer retina), which provide …

Over the past several decades, vascular endothelial growth factor (VEGF) has become
recognized as an important pathologic angiogenic factor in several eye diseases, including …